These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Mucopolysaccharidosis III in Mainland China: natural history, clinical and molecular characteristics of 34 patients. Kong W; Meng Y; Zou L; Yang G; Wang J; Shi X J Pediatr Endocrinol Metab; 2020 May; 33(6):793-802. PubMed ID: 32447333 [TBL] [Abstract][Full Text] [Related]
5. Natural history of Sanfilippo syndrome in Spain. Delgadillo V; O'Callaghan Mdel M; Gort L; Coll MJ; Pineda M Orphanet J Rare Dis; 2013 Dec; 8():189. PubMed ID: 24314109 [TBL] [Abstract][Full Text] [Related]
6. Hematopoietic stem cell transplantation in mucopolysaccharidosis type IIIA: A case description and comparison with a genotype-matched control group. Köhn AF; Grigull L; du Moulin M; Kabisch S; Ammer L; Rudolph C; Muschol NM Mol Genet Metab Rep; 2020 Jun; 23():100578. PubMed ID: 32226768 [TBL] [Abstract][Full Text] [Related]
7. What Can We Learn from the Parents of Children Affected with Mucopolysaccharidosis Type III-A in Israel? Liber S; Staretz-Chacham O; Kishon M; Pode-Shakked B; Chorin O; Kneller K; Anikster Y; Mangisto G; Saada A; Raas-Rothschild A Mol Syndromol; 2022 Feb; 13(1):45-49. PubMed ID: 35221874 [TBL] [Abstract][Full Text] [Related]
11. The First Reported Case of Hyperreninemic Hypoaldosteronism Due to Mucopolysaccharidosis Disorder. Gayed A; Schott VA; Meltzer L Cureus; 2020 Jun; 12(6):e8487. PubMed ID: 32656005 [TBL] [Abstract][Full Text] [Related]
12. [Hyperactivity and behavioral disorders in Sanfilippo A (mucopolysaccharidosis type IIIA)--case report and review of the literature]. Wolańczyk T; Banaszkiewicz A; Mierzewska H; Czartoryska B; Zdziennicka E Psychiatr Pol; 2000; 34(5):831-7. PubMed ID: 11202024 [TBL] [Abstract][Full Text] [Related]
13. Female mucopolysaccharidosis IIIA mice exhibit hyperactivity and a reduced sense of danger in the open field test. Langford-Smith A; Langford-Smith KJ; Jones SA; Wynn RF; Wraith JE; Wilkinson FL; Bigger BW PLoS One; 2011; 6(10):e25717. PubMed ID: 22028789 [TBL] [Abstract][Full Text] [Related]
14. Sanfilippo type A: new clinical manifestations and neuro-imaging findings in patients from the same family in Israel: a case report. Sharkia R; Mahajnah M; Zalan A; Sourlis C; Bauer P; Schöls L J Med Case Rep; 2014 Feb; 8():78. PubMed ID: 24576347 [TBL] [Abstract][Full Text] [Related]
15. Neuronal-specific impairment of heparan sulfate degradation in Drosophila reveals pathogenic mechanisms for Mucopolysaccharidosis type IIIA. Webber DL; Choo A; Hewson LJ; Trim PJ; Snel MF; Hopwood JJ; Richards RI; Hemsley KM; O'Keefe LV Exp Neurol; 2018 May; 303():38-47. PubMed ID: 29408731 [TBL] [Abstract][Full Text] [Related]
16. The mutation p.Ser298Pro in the sulphamidase gene (SGSH) is associated with a slowly progressive clinical phenotype in mucopolysaccharidosis type IIIA (Sanfilippo A syndrome). Meyer A; Kossow K; Gal A; Steglich C; Mühlhausen C; Ullrich K; Braulke T; Muschol N Hum Mutat; 2008 May; 29(5):770. PubMed ID: 18407553 [TBL] [Abstract][Full Text] [Related]